EUGIA PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and when can generic versions of EUGIA PHARMA drugs launch?
EUGIA PHARMA has one hundred and sixty-nine approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and fifty-one supplementary protection certificates in eighteen countries.
Summary for EUGIA PHARMA
International Patents: | 10 |
US Patents: | 1 |
Tradenames: | 143 |
Ingredients: | 135 |
NDAs: | 169 |
Patent Litigation for EUGIA PHARMA: | See patent lawsuits for EUGIA PHARMA |
Drugs and US Patents for EUGIA PHARMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eugia Pharma | TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 217519-001 | Jun 21, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Eugia Pharma | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 216244-002 | Mar 21, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Eugia Pharma | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 213885-002 | Mar 6, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for EUGIA PHARMA Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 20170008252 | ⤷ Sign Up |
European Patent Office | 3139929 | ⤷ Sign Up |
China | 106456654 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for EUGIA PHARMA Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1411900 | SPC/GB11/015 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
0440372 | SPC/GB02/031 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: VORICONAZOLE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/02/212/001-025 20020319 |
2371361 | LUC00139 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: PLERIXAFOR EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE OU UN COMPLEXE METALLIFERE QUI EN DERIVE; AUTHORISATION NUMBER AND DATE: EU/1/09/537/001 20090804 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.